1. Scannell, J.W. et al. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 11, 191–200 (2012).
2. Tollman, P. et al. Unlocking productivity in biopharmaceutical R&D: The key to outperforming. BCG Perspectives. Jan 2016.
https://www.bcgperspectives.com/content/articles/biopharmaceuticals-people-organization-unlocking-productivity-biopharma-r-and-d/
3. Tollman, P. et al. Can R&D be fixed? Lessons from biopharma outliers. BCG Perspectives. Sep 2011.
https://www.bcgperspectives.com/content/articles/biopharmaceuticals_innovation_can_r_and_d_be_fixed/
4. Morieux, Y. & Tollman, P. Six Simple Rules: How to Manage Complexity Without Getting Complicated. Harvard Business Review Press (2014).
5. Peck, R.W. et al. Why is it hard to terminate failing projects in pharmaceutical R&D? Nat. Rev. Drug Discov. 14, 663–664 (2015).